Akari Therapeutics PLC (AKTX) vs MARKER THERAPEUTICS, INC. (MRKR)
Akari Therapeutics PLC and MARKER THERAPEUTICS, INC. are both Biotechnology companies. MARKER THERAPEUTICS, INC. is the larger, with a market value of $19.8M against $17.6M — 1.1× the size. Across the 11 metrics below, Akari Therapeutics PLC leads on 6 and MARKER THERAPEUTICS, INC. on 5.
Valuation
Profitability
| Metric | AKTX | MRKR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (140.09%) | (76.87%) | (57.72%) |
| Return on assets | (69.16%) | (59.33%) | (49.22%) |
| Return on invested capital | (167.93%) | (566.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack